Jazz Pharmaceuticals | JAZZ - Loan Capital

JAZZ PHA reported $5.69B in Loan Capital for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Loan Capital Change
ALKERMES ALKS:US USD 290.27M 634K
Coherus Biosciences CHRS:US USD 472.48M 1.98M
Emergent Biosolutions EBS:US USD 448.5M 583.6M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.05B
Halozyme Therapeutics HALO:US USD 1.49B 1.61M
Heron Therapeutics HRTX:US USD 149.23M 52K
Hikma Pharmaceutical HIK:LN USD 1.14B 279M
Horizon Pharma HZNP:US USD 2.55B 2.3M
IONIS PHARMACEUT IONS:US USD 1.18B 66.78M
Mckesson MCK:US USD 5.45B 639M
Pacira Pharmaceuticals PCRX:US USD 655.82M 58.18M
Perrigo Ordinary Shares PRGO:US USD 4.07B 7.1M
Phibro Animal Health PAHC:US USD 460.81M 9.07M
Revance Therapeutics RVNC:US USD 379.37M 485K
Teva Pharmaceutical Industries TEVA:US USD 19.1B 606M
Xeris Pharmaceuticals Inc XERS:US USD 187.08M 48.57M
Zoetis ZTS:US USD 6.55B 1.34B